FRANKFURT/ATHENS (Reuters) - German pharmaceutical firm Biotest said it would stop shipments to Greece in July, becoming the first drugmaker to announce it would quit the debt-mired country's market because its bills had not been paid. Though a relatively small player in Greece, the company's exit sets an unwelcome precedent for a country whose healthcare system is crumbling under the weight of economic crisis and administrative deadlock. ... Click here to read the rest
No comments:
Post a Comment